Papadatos-Pastos, D;    Yuan, W;    Pal, A;    Crespo, M;    Ferreira, A;    Gurel, B;    Prout, T;                                                                                                 ... Minchom, A; + view all <#>        Papadatos-Pastos, D;  Yuan, W;  Pal, A;  Crespo, M;  Ferreira, A;  Gurel, B;  Prout, T;  Ameratunga, M;  Chénard-Poirier, M;  Curcean, A;  Bertan, C;  Baker, C;  Miranda, S;  Masrour, N;  Chen, W;  Pereira, R;  Figueiredo, I;  Morilla, R;  Jenkins, B;  Zachariou, A;  Riisnaes, R;  Parmar, M;  Turner, A;  Carreira, S;  Yap, C;  Brown, R;  Tunariu, N;  Banerji, U;  Lopez, J;  De Bono, J;  Minchom, A;   - view fewer <#>    (2022)    Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors.                   Journal for ImmunoTherapy of Cancer , 10  (6)    , Article e004495.  10.1136/jitc-2022-004495 <https://doi.org/10.1136/jitc-2022-004495>.       Green open access